More TrivarX Limited news
TrivarX LimitedASX: TRI

Voluntary Suspension

Jun 16, 2022 at 12:17 AM EDT · Issued by TrivarX Limited

Filed with ASX · Jun 16, 2022 at 12:17 AM EDT

On 6ix: 6ix.com/news/voluntary-suspension-72

Trivarx Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

TrivarX Limited on 6ix

Story so far

  • Suspension from Official QuotationJul 9, 2019

Earlier from TrivarX

  • FDA Confirm Diagnostic Method on Depression Validation TrialMay 18, 2022
  • Medibio Announces Entitlement Offer ResultMar 10, 2022
  • Termination of Underwriting AgreementMar 1, 2022
  • Non-Renounceable Entitlement Offer Underwriting UpdateJan 20, 2022
  • MEB to Raise up to $5.7 million by way of a Placement & NREODec 14, 2021

Later from TrivarX

  • Reinstatement to QuotationJun 22, 2022
  • MEB to Raise $1.4m by way of a Placement & MD/CEO ResignsJun 22, 2022
  • Sleep Analysis Depressive Burden Study Clinical TrialJul 20, 2022
  • Appendix 4E and Preliminary Final ReportAug 31, 2022
  • Medibio Appoints CEOSep 19, 2022
All TrivarX news releases↗

Follow TrivarX into a list and get an email when it puts out news.

Follow TrivarX
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer